23 related articles for article (PubMed ID: 15023462)
1. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride.
Al-Saidan SM; Krishnaiah YS; Patro SS; Satyanaryana V
AAPS PharmSciTech; 2005 Jul; 6(1):E14-21. PubMed ID: 16353958
[TBL] [Abstract][Full Text] [Related]
2. Development of orally disintegrating tablets comprising controlled-release multiparticulate beads.
Venkatesh GM; Stevens PJ; Lai JW
Drug Dev Ind Pharm; 2012 Dec; 38(12):1428-40. PubMed ID: 22356215
[TBL] [Abstract][Full Text] [Related]
3. Formulation of a novel tianeptine sodium orodispersible film.
El-Setouhy DA; Abd El-Malak NS
AAPS PharmSciTech; 2010 Sep; 11(3):1018-25. PubMed ID: 20532710
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound transmission technique as a potential tool for physical evaluation of monolithic matrix tablets.
Hakulinen MA; Pajander J; Leskinen J; Ketolainen J; van Veen B; Niinimäki K; Pirskanen K; Poso A; Lappalainen R
AAPS PharmSciTech; 2008; 9(1):267-73. PubMed ID: 18446491
[TBL] [Abstract][Full Text] [Related]
5. Convolution- and Deconvolution-Based Approaches for Prediction of Pharmacokinetic Parameters of Diltiazem Extended-Release Products in Flow-Through Cell Dissolution Tester.
Taha NF; Emara LH
AAPS PharmSciTech; 2022 Jul; 23(6):202. PubMed ID: 35882726
[TBL] [Abstract][Full Text] [Related]
6. An engineering approach to biomedical sciences: advanced testing methods and pharmacokinetic modeling.
Lamberti G; Cascone S; Titomanlio G
Transl Med UniSa; 2012 Sep; 4():34-8. PubMed ID: 23905061
[TBL] [Abstract][Full Text] [Related]
7. Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks.
Mendyk A; Tuszyński PK; Polak S; Jachowicz R
Drug Des Devel Ther; 2013; 7():223-32. PubMed ID: 23569360
[TBL] [Abstract][Full Text] [Related]
8. Recent advances of starch-based excipients used in extended-release tablets: a review.
Hong Y; Liu G; Gu Z
Drug Deliv; 2016; 23(1):12-20. PubMed ID: 24833274
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
11. In vivo performance of controlled release pellets of diltiazem HCl.
Nisarur-ur-Rahman ; K H Y; Jia Woei W
Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability of two tablet preparations of diltiazem in healthy volunteers.
De Bernardis E; Candido P; Lorefice R; Picari M; Rizza V
Arzneimittelforschung; 1992 Jan; 42(1):25-7. PubMed ID: 1586376
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
14. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
